AU Patent

AU2008206231A1 — Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents

Assigned to Takeda Pharmaceuticals USA Inc · Expires 2008-07-24 · 18y expired

What this patent protects

Patent listed against Zurampic.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008206231A1
Jurisdiction
AU
Classification
—
Expires
2008-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceuticals USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.